Is Ozempic a Once a Week Injection?

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Yes, Ozempic is administered as a once-weekly injection containing the GLP-1 receptor agonist semaglutide. The medication has become widely recognized for its role in weight loss and type 2 diabetes management, with clinical trials showing average weight reductions of 5 to 10 percent over 68 weeks. PlexusDx provides access to compounded semaglutide injection through licensed 503A pharmacies, offering the same active ingredient at a flat monthly price at $189/mo month-to-month, or from $149/mo on the 6-month plan.

How Ozempic Works as a Weekly Injection

Semaglutide in Ozempic mimics glucagon-like peptide-1 (GLP-1), a natural hormone that regulates appetite and blood sugar levels. When injected once per week under the skin, the medication activates GLP-1 receptors in the brain and digestive tract, slowing gastric emptying and increasing feelings of fullness. This mechanism allows users to consume fewer calories while maintaining stable energy levels throughout the week.

The once-weekly dosing schedule stems from semaglutide's extended half-life, meaning the medication remains active in your system for approximately 7 days after injection. This design eliminates the need for daily dosing and improves treatment adherence compared to shorter-acting alternatives. Patients typically inject on the same day each week, creating a simple routine that fits most lifestyles.

Ozempic Dosing Schedule and Dose Escalation

Ozempic treatment begins with a low starting dose of 0.25 mg, which is increased gradually every four weeks based on tolerance and clinical response. Most patients reach a maintenance dose between 0.5 mg and 2.4 mg weekly, though individual needs vary significantly. The gradual titration approach minimizes gastrointestinal side effects while allowing the body to adapt to the medication.

Dose adjustments are made by a healthcare provider based on your weight loss progress, blood sugar targets, and how well you tolerate each dose level. Some individuals require higher doses for optimal results, while others achieve their goals at lower maintenance levels. PlexusDx works with practitioners to tailor semaglutide dosing to your specific health profile, and your dose may need to go up—but your price won't, as PlexusDx charges a flat monthly rate regardless of dose strength.

Compounded Semaglutide vs. Branded Ozempic

Compounded semaglutide injection and Ozempic contain the identical active pharmaceutical ingredient but differ in cost, availability, and manufacturing standards. Ozempic is manufactured by Novo Nordisk as a branded pharmaceutical, while PlexusDx sources compounded semaglutide from licensed 503A pharmacies that follow strict FDA-regulated compounding practices. Both deliver semaglutide through once-weekly injection and produce comparable clinical outcomes.

The primary advantage of PlexusDx compounded semaglutide is accessibility and affordability, at $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance requirements or membership fees. PlexusDx serves all 50 states and accepts HSA and FSA contributions for added savings. Licensed 503A compounding pharmacies must meet rigorous quality standards for sterility, potency, and purity, ensuring you receive consistent medication with each injection.

Personalized GLP-1 Therapy and Genetic Testing

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Do I need to take Ozempic every day, or is it truly once weekly?

Ozempic is administered as a once-weekly injection, not daily. You inject under the skin on the same day each week, and the medication remains active for 7 days due to semaglutide's extended half-life. PlexusDx compounded semaglutide injection follows the same once-weekly dosing schedule, offering the same convenience at a flat monthly price.

How much weight can I expect to lose with semaglutide injections?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I switch from Ozempic to PlexusDx compounded semaglutide?

Yes, you can transition from Ozempic to PlexusDx compounded semaglutide injection, which contains the same active ingredient and uses the same once-weekly injection schedule. Your provider will confirm the transition, and you'll begin paying a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance requirements. PlexusDx serves all 50 states with HSA and FSA eligibility.

What are the most common side effects of semaglutide injections?

The most frequent side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose escalation in the first weeks of treatment. These effects typically decrease as your body adapts and usually resolve within 2 to 4 weeks per dose increase. Eating smaller meals, staying hydrated, and pacing food intake can minimize gastrointestinal discomfort during semaglutide therapy.

How does genetic testing improve my semaglutide treatment results?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (FTO (rs9939609)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Injection Ozempic
• Injection Sites For Ozempic
• Ozempic Injection Sites
• Ozempic Injection

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.